loading

Iteos Therapeutics Inc Borsa (ITOS) Ultime notizie

pulisher
01:44 AM

Wedbush Research Analysts Cut Earnings Estimates for ITOS - Defense World

01:44 AM
pulisher
Jul 25, 2025

iTeos Therapeutics Inc. Stock Analysis and ForecastRecord-breaking capital gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will iTeos Therapeutics Inc. stock split in the near futureHigh-yield investments - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Q2 EPS Estimate for iTeos Therapeutics Lowered by Analyst - Defense World

Jul 25, 2025
pulisher
Jul 24, 2025

SHAREHOLDER ALERT: Morris Kandinov Investigating AVDX, - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about iTeos Therapeutics Inc. stockFree Stock Market Knowledge Sharing - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Is iTeos Therapeutics Inc. stock overhyped or has real potentialFree Predictions - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives iTeos Therapeutics Inc. stock priceRapid growth opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Assessing the Fairness of iTeos Therapeutics' $10.047-per-Share Acquisition Offer: A Valuation Deep Dive - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ITEOS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iTeos Therapeutics, Inc.ITOS - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Is iTeos Therapeutics Inc. a good long term investmentHigh-profit trading signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

iTeos Therapeutics accepts takeover bid from Concentra - The Pharma Letter

Jul 22, 2025
pulisher
Jul 22, 2025

Concentra buys beleaguered iTeos at slight discount - PharmaLive

Jul 22, 2025
pulisher
Jul 22, 2025

iTeos Therapeutics stock price target lowered to $10 at Leerink Partners - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

iTeos Therapeutics (NASDAQ:ITOS) Given Outperform Rating at Wedbush - Defense World

Jul 22, 2025
pulisher
Jul 22, 2025

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of ITeos Therapeutics, Inc. - 富途牛牛

Jul 22, 2025
pulisher
Jul 21, 2025

Securities Law Risks in Biotech M&A: A Closer Look at iTeos Therapeutics' Proposed Acquisition - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 21, 2025

Rowley Law PLLC Investigates iTeos Therapeutics Acquisition for Securities Law Violations - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of iTeos Therapeutics, Inc. - ETX View

Jul 21, 2025
pulisher
Jul 21, 2025

Navigating ITOS Stock: ITeos Therapeutics Inc Journey - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

iTeos Therapeutics To Be Acquired by Concentra Biosciences - citybiz

Jul 21, 2025
pulisher
Jul 21, 2025

ITOS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iTeos Therapeutics, Inc. Is Fair to Shareholders - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

Concentra To Acquire ITeos - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

The Strategic Rationale and Valuation Implications of Concentra Biosciences' Acquisition of iTeos Therapeutics - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

iTeos Therapeutics, Inc. Enters Merger Agreement with Concentra Biosciences, LLC for $10.047 per Share Acquisition - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

iTeos Therapeutics Enters into Agreement to Be Acquired by - GlobeNewswire

Jul 21, 2025
pulisher
Jul 19, 2025

iTeos Announces 2025 Strategic Priorities and Anticipated Milestones - Informazione.it

Jul 19, 2025
pulisher
Jul 18, 2025

What risks could impact iTeos Therapeutics Inc. stock performanceFree Stock Index Interpretation - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace

Jul 18, 2025
pulisher
Jul 17, 2025

GSK and Iteos Therapeutics’ Promising Phase 3 Study on NSCLC Treatment - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

How iTeos Therapeutics Inc. stock performs during market volatilityFree Stock Market Expert Consultation - Newser

Jul 17, 2025
pulisher
Jul 16, 2025

GSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab - The Globe and Mail

Jul 16, 2025
pulisher
Jul 15, 2025

What makes iTeos Therapeutics Inc. stock price move sharplyStrategic High Profit Opportunities - Newser

Jul 15, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):